Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 271 - 280 of 428

Selected Filters:
10 November 2022

Bottlenecks and Solutions During Implementation of the DREAMS Program for Adolescent Girls and Young Women in Namibia

This article from Global Health: Science and Practice synthesizes implementation bottlenecks experienced while implementing the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) program, an HIV prevention intervention for adolescent girls and young women (AGYW) in Namibia from 2017 to 2019, highlighting practical implementation issues and higher-level considerations for AGYW-centered HIV prevention programs.

Research

External Link
10 November 2022

Qualitative Inquiry into Perceptions of HIV Pre-exposure Prophylaxis among People who Inject Drugs Living with Hepatitis C in Seattle, WA, USA

This article from Harm Reduction Journal explores knowledge, attitudes, and perspectives of PrEP acceptability among people who use drugs in Seattle, Washington, USA.

Research

External Link
9 November 2022

Not PrEPared: Barriers to accessing HIV prevention drugs in England

In order to get a more comprehensive picture on what is happening with PrEP services across the UK, Terrence Higgins Trust, National AIDS Trust, PrEPster, Sophia Forum, and One Voice Network collected data from local authority sexual health commissioners, clinical staff, PrEP users, and those who sought to access PrEP. This report summarizes the findings,…

Research

Document
7 November 2022

More than Vessels: Pregnant People Deserve Inclusion in HIV Prevention Clinical and Implementation Research

Recording / Slides / Resources Pregnancy and the post-partum period after giving birth are times of heightened HIV risk. Cisgender women are two to three times more likely to acquire HIV during pregnancy and four times more likely post-partum than otherwise. Women who acquire HIV during pregnancy have an 18 percent chance of transmitting HIV…

Research

Event
3 November 2022

ICAP Grand Rounds Webinar- Long-Acting Injectable Cabotegravir for HIV Prevention: Promises and Pitfalls

Recording / Slides Two recent landmark HIV Prevention Trials Network (HPTN) studies demonstrated the efficacy of long-acting, injectable cabotegravir (CAB) as PrEP against HIV. These studies showed that CAB for PrEP injected once every eight weeks was superior to daily oral tenofovir/emtricitabine (TDF/FTC) for PrEP among cisgender men and transgender women who have sex with…

Research

Event
3 November 2022

MATRIX Project Overview

This factsheet provides an overview of USAID’s Microbicide Research and Development to Advance HIV Prevention Technologies through Responsive Innovations and Excellence (MATRIX) project.

Community/Advocacy, Research

Document
2 November 2022

PrEP-Related Stigma and PrEP Use among Gay, Bisexual and Other Men who Have Sex with Men in Ontario and British Columbia, Canada

This article from AIDS Research and Therapy explores the association between PrEP-related stigma and PrEP use amongst gay and bisexual men who have sex with men in Ontario and British Columbia, Canada.

Research, Service Delivery

External Link
1 November 2022

The Importance of Assessing and Addressing Mental Health Barriers to PrEP Use during Pregnancy and Postpartum in Sub-Saharan Africa: State of the science and research priorities

This article from the Journal of the International AIDS Society highlights key research priorities that can support PrEP adherence and persistence during pregnancy and the post-partum period by addressing mental health barriers.

Research, Service Delivery

External Link
20 October 2022

Dual Prevention Pill Research Insights & Development of Strategic Themes

This presentation, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.

Research

Presentation
20 October 2022

Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study

This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.

Research

External Link